Denise MuellerChief Business Officer at AffimedSpeaker
Profile
Ms. Mueller is an accomplished executive who joined Affimed in 2016 as Chief Business Officer. She brings to the company over 20 years of commercial, brand and marketing expertise, having supported the domestic and global launch of new products and line extensions. Before joining Affimed, Ms. Mueller held various leadership roles in the U.S. and globally during her 17-year tenure at Wyeth Pharmaceuticals and, subsequently, Pfizer, following the organizations’ merger. Among other Pfizer roles, she served as Disease Area Lead for multiple therapeutic areas, and was responsible for developing disease area and indication strategy, commercial development and market shaping.
In addition to her broad and extensive commercial experience, Ms. Mueller led and managed two of Pfizer’s largest alliances and was the business development lead for Pfizer’s rare disease business unit.
During her career with Pfizer, she gained broad and deep commercial expertise through her roles as the Director of Strategy, Director of External Opportunities, and Director/Worldwide Commercial Lead of multiple in-line and pipeline assets. She enabled the PFE Specialty Care business to expand into the gene therapy business and new gastrointestinal therapeutic areas.
As the Director and Global Business Manager, Ms. Mueller had in-line responsibility for a product that delivered 850 million dollar in revenue through a strategic partnership with Medtronic.
Ms. Mueller began her health care career in hospital management, where she ran emergency medicine, critical care, in-house pediatrics and hospitalist programs. She received her Bachelor of Arts in Mathematics from Virginia Polytechnic Institute and State University.